Sobel B E
Am Heart J. 1982 Apr;103(4 Pt 2):673-81. doi: 10.1016/0002-8703(82)90473-2.
Cardiac positron tomography offers promise as a diagnostic tool with attributes permitting characterization of regional myocardial biochemistry and perfusion in quantitative terms. Its availability should facilitate the detection, localization, and characterization of metabolic sequelae of ischemia and impaired perfusion. Its power to elucidate intermediary metabolism in vivo should help clarify the pathogenesis and promote early detection of differentiation of specific cardiomyopathic processes, currently unrecognizable except in terms of end-stage functional and morphologic criteria. Its quantitative characteristics are amenable to sequential application and should facilitate objective evaluations of interventions designed to maintain or improve biochemical integrity in jeopardized myocardium in patients with ischemic heart disease.
心脏正电子断层扫描作为一种诊断工具具有很大前景，其特性允许对局部心肌生物化学和灌注进行定量描述。它的应用应有助于检测、定位和描述缺血及灌注受损的代谢后遗症。其在体内阐明中间代谢的能力应有助于阐明发病机制，并促进对特定心肌病过程的早期检测和鉴别，目前这些过程除非根据终末期功能和形态学标准，否则难以识别。其定量特性适合于连续应用，并应有助于对旨在维持或改善缺血性心脏病患者濒危心肌生化完整性的干预措施进行客观评估。
